Role of blood pressure in the progression of microalbuminuria in elderly Japanese type 2 diabetic patients: a 7-year follow-up study

被引:9
作者
Ito, Y
Utsugi, T
Ohyama, Y
Ohno, T
Uchiyama, T
Tomono, S
Kawazu, S
Kurabayashi, M
机构
[1] Gunma Univ, Sch Med, Dept Internal Med 2, Gunma 3718511, Japan
[2] Gunma Prefectural Cardiovasc Ctr, Dept Internal Med, Gunma, Japan
[3] Gunma Univ, Sch Med, Dept Hlth Sci, Gunma, Japan
[4] Saitama Med Sch, Saitama Med Ctr, Saitama, Japan
关键词
microalbuminuria; type; 2; diabetes; elderly; blood pressure; systolic blood pressure;
D O I
10.1177/147323000102900403
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
This 7-year retrospective longitudinal study was carried out in order to clarify the clinical features of elderly type 2 diabetic patients with microalbuminuria. Elderly Japanese type 2 diabetic patients (n = 22; age 50 - 73 years) with microalbuminuria were studied retrospectively. Patients whose urinary albumin excretion rate (UAER) decreased over 7 years were considered 'non-progressors' (n = 8) whereas those whose UAER increased were considered 'progressors' (n = 14). The mean 7-year level of glycosylated haemoglobin (HbA(1c)) did not differ significantly between non-progressors and progressors but the mean 7-year blood pressure (BP) of progressors (101 +/- 8 mmHg) was significantly higher than that of nonprogressors (92 +/- 7 mmHg). In progressors who received no anti-hypertensive drugs, systolic BP was above the BP goal of 130/85 mmHg but mean BP and diastolic BP were below this goal. The results are consistent with the view that hypertension affects the progression of microalbuminuria; raised systolic BP may be a factor in this progression in elderly type 2 diabetic patients.
引用
收藏
页码:280 / 286
页数:7
相关论文
共 19 条
[1]
[Anonymous], 1994, DIABETES CARE, V17, P1357
[2]
APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes -: Results of case-control and family-based studies [J].
Araki, S ;
Moczulski, DK ;
Hanna, L ;
Scott, LJ ;
Warram, JH ;
Krolewski, AS .
DIABETES, 2000, 49 (12) :2190-2195
[3]
Association of apolipoprotein ε2 allele with diabetic nephropathy in Caucasian subjects with IDDM [J].
Chowdhury, TA ;
Dyer, PH ;
Kumar, S ;
Gibson, SP ;
Rowe, BR ;
Davies, SJ ;
Marshall, SM ;
Morris, PJ ;
Gill, GV ;
Feeney, S ;
Maxwell, P ;
Savage, D ;
Boulton, AJM ;
Todd, JA ;
Dunger, D ;
Barnett, AH ;
Bain, SC .
DIABETES, 1998, 47 (02) :278-280
[4]
CULL C, 1993, DIABETOLOGIA, V36, P1021
[5]
Doi Y, 1996, DIABETOLOGIA, V39, P97
[6]
Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: Prospective, observational study [J].
Gall, MA ;
Hougaard, P ;
BorchJohnsen, K ;
Parving, HH .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 314 (7083) :783-788
[7]
HARRIS MI, 1995, DIABETES AM, P117
[8]
PHENOTYPES OF APOLIPOPROTEIN-E AND ABNORMALITIES IN LIPID-METABOLISM IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
IMARI, Y ;
KOGA, S ;
IBAYASHI, H .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1988, 37 (12) :1134-1138
[9]
Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM [J].
Kimura, H ;
Suzuki, Y ;
Gejyo, F ;
Karasawa, R ;
Miyazaki, R ;
Suzuki, S ;
Arakawa, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) :666-673
[10]
United kingdom prospective diabetes study, 30 - Diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus ann associated risk factors [J].
Kohner, EM ;
Aldington, SJ ;
Stratton, IM ;
Manley, SE ;
Holman, RR ;
Matthews, DR ;
Turner, RC .
ARCHIVES OF OPHTHALMOLOGY, 1998, 116 (03) :297-303